Mounjaro is a GLP-1 and GIP receptor agonist that regulates blood sugar and appetite
By activating GIP receptors, tirzepatide enhances insulin secretion in a glucose-dependent manner, meaning insulin release occurs primarily when blood glucose levels are elevated, thereby reducing the risk of hypoglycemia
They attached a long chain of lipids that can bind to albumin a protein in blood that serves as a carrier for the drugand keep the compound active for hours or even days
Creates slight prolactin and cortisol issues
As usual in health plan administration, the answer is layered and not entirely straightforward
Not only are there currently millions of people on these compounded drugs, all of whom would have to get new prescriptions to switch over to brand-name ones, but the market is ever-growing as these drugs gain new approved uses, like sleep apnea